Administration of recombinant human thrombopoietin is associated with alleviated thrombocytopenia in adult intensive care unit patients with pneumonia: A single-center retrospective study

Background: Recombinant human thrombopoietin (rhTPO) is reported to stimulate platelet production and increase peripheral platelet counts; it is primarily used to manage chemotherapy-induced thrombocytopenia and idiopathic thrombocytopenic purpura. However, the effect of rhTPO in patients with pneum...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bailiang, Xuan, Jiabin, Wu, Feng, Shi, Nengxian, Dai, Jianwei, Cai, Shumin, An, Shengli, Huang, Qiaobing, Huang, Xiaoling, Chen, Zhongqing, Zeng, Zhenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589100/
https://www.ncbi.nlm.nih.gov/pubmed/36299903
http://dx.doi.org/10.3389/fphar.2022.1007719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589100/
https://www.ncbi.nlm.nih.gov/pubmed/36299903
http://dx.doi.org/10.3389/fphar.2022.1007719

Ejemplares similares